Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGEN CORPNEOG · Entity 4338 | Director | October 06, 2022 | October 11, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGEN CORP
Report date October 06, 2022 · Filed October 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.28 · Expires 2029-10-06 | Direct | 50,501 |
Reported balance
After 2022-10-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-10-06 · Exercise / conversion · Acquired 18,416 · Balance 50,501 F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $13.28 · Expires 2025-10-06 | Direct | 6,968 |
Reported balance
After 2022-10-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-10-06 · Exercise / conversion · Acquired 6,212 · Balance 6,968 F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants |
Filing footnotes · ownership attribution and instrument terms
F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2022 Filed Oct 11, 2022 20:54 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 6,212 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000711377-22-000021 · primary_doc.xml · derivative · entry 2 Vetter Darci L · CIK 0001719291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,968 Underlying: Common Stock · 6,212 shares Expires 2025-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 06, 2022 Filed Oct 11, 2022 20:54 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 18,416 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000711377-22-000021 · primary_doc.xml · derivative · entry 1 Vetter Darci L · CIK 0001719291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,501 Underlying: Common Stock · 18,416 shares Expires 2029-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 00:15 UTC | NEOGEN CORP NEOG · Entity 4338 | PurchaseCommon Stock | 1,100 | $21.83 | $24,013.00 |
DisclosureSEC source: 0000711377-22-000012 · primary_doc.xml · nonDerivative · entry 1 Vetter Darci L · CIK 0001719291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,384 Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 21:56 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 707 | $0.00 Strike: $42.45 | $0.00 |
DisclosureSEC source: 0000711377-21-000028 · primary_doc.xml · derivative · entry 2 Vetter Darci L · CIK 0001719291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,273 Underlying: Common Stock · 707 shares Expires 2024-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: RSUs vest in three equal annual installments, vesting on each of the first three anniversary dates of the grant Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 21:56 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 2,971 | $0.00 Strike: $42.45 | $0.00 |
DisclosureSEC source: 0000711377-21-000028 · primary_doc.xml · derivative · entry 1 Vetter Darci L · CIK 0001719291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,085 Underlying: Common Stock · 2,971 shares Expires 2026-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options have five year lives, and vest in three equal annual installments on each of the first three anniversary dates of the grant Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 21:14 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Unit · Derivative | 425 | $0.00 Strike: $70.55 | $0.00 |
DisclosureSEC source: 0000711377-20-000036 · primary_doc.xml · derivative · entry 2 Vetter Darci L · CIK 0001719291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425 Underlying: Common Stock · 425 shares Expires 2023-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: RSUs vest in equal 33% annual installments on each of the first three anniversary dates of the grant Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 21:14 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 1,890 | $0.00 Strike: $70.55 | $0.00 |
DisclosureSEC source: 0000711377-20-000036 · primary_doc.xml · derivative · entry 1 Vetter Darci L · CIK 0001719291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,557 Underlying: Common Stock · 1,890 shares Expires 2025-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options have a five year life and vest in equal 33% annual installments on each of the first three anniversary dates of the grant Read SEC document |
| October 03, 2019 Filed Oct 7, 2019 21:31 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $64.19 | $0.00 |
DisclosureSEC source: 0000711377-19-000042 · primary_doc.xml · derivative · entry 1 Vetter Darci L · CIK 0001719291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,667 Underlying: Common Stock · 3,000 shares Expires 2024-10-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options have five year lives, and vest in three equal annual installments on each of the first three anniversary dates of the grant Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 21:34 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $67.72 | $0.00 |
DisclosureSEC source: 0000711377-18-000039 · primary_doc.xml · derivative · entry 1 Vetter Darci L · CIK 0001719291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,667 Underlying: Common Stock · 3,000 shares Expires 2023-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options were granted 10/42018, vest in three equal annual installments on each of the first three anniversary dates of the grant, and have five year lives Read SEC document |
| October 05, 2017 Filed Oct 11, 2017 20:32 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0000711377-17-000040 · primary_doc.xml · derivative · entry 1 Vetter Darci L · CIK 0001719291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2027-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options have ten year lives and vest in 33% annual installments on each of the first three anniversary dates of the grant Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.